JMF
IONS icon

Johnson Midwest Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Johnson Midwest Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.68K Hold
59
– – 0.01% 300
2023
Q2 		$2.42K Hold
59
– – ﹤0.01% 303
2023
Q1 		$2.11K Hold
59
– – ﹤0.01% 321
2022
Q4 		$2K Buy
+59
New +$2.48K 0.01% 321

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Johnson Midwest Financial's IONS Position: Q3 2023 in Review

Johnson Midwest Financial held its Ionis Pharmaceuticals (IONS) position steady in Q3 2023 at 59 shares worth $2.68K. The position accounts for 0.01% of the portfolio, ranked #300.

Johnson Midwest Financial first reported a position in IONS in Q4 2022 and has held it in 4 quarters since. 310 funds tracked by Wall St. Rank hold IONS as of Q3 2023.

  • Johnson Midwest Financial held 59 shares of Ionis Pharmaceuticals worth $2.68K as of Q3 2023.
  • Johnson Midwest Financial left its Ionis Pharmaceuticals share count unchanged in Q3 2023.
  • Ionis Pharmaceuticals made up 0.01% of Johnson Midwest Financial's portfolio in Q3 2023, its #300 holding.
  • Johnson Midwest Financial first reported a position in Ionis Pharmaceuticals in Q4 2022 and has held it in 4 quarters since.
  • 310 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.